Baxter Healthcare Corporation's BioPharma Solutions Business - Formulation, Contract Manufacturing and Proprietary Packaging Technologies

The stakes in drug development are high. We’ve put together a dynamic portfolio of formulation, manufacturing and packaging services to support your efforts throughout every phase of the drug development process.

At Baxter, we work with you to find just the right solution for you and your product. Our services are built around two driving principles:

• Solutions that enable - our goal is to help you overcome the challenges you face to make your drug a reality
• Solutions that enhance - we can help extend the life of your product, enhancing its value in the marketplace

Whether your molecule is in the early stages of development or nearing patent expiry, Baxter can be your outsource partner. With Baxter, you can connect to the resources you need.

Our portfolio of services includes formulation technology, contract services and enhanced packaging.

FORMULATION TECHNOLOGY

Our unique, proprietary technologies and expertise provide tools for solving your drug delivery problems. We offer you the potential to develop safe, efficacious and competitive drugs.

Our formulation capabilities include:

• Solubilisation technology
• Controlled release technology
• Formulation development expertise
• Broad parenteral capabilities including protein stabilization; freeze dry product and process development
• Scale up
• Expertise includes feasibility and toxicology evaluation, clinical supplies, and commercialisation

SOLUBILISATION TECHNOLOGY

NANOEDGE dispersion technologies for insoluble drugs offer powerful strategies for overcoming solubility challenges and accelerating drug development. NANOEDGE nanosuspension platforms produce a wide range of dissolution profiles, including rapid delivery, sustained release and extended release.

CONTROLLED DRUG RELEASE TECHNOLOGY

PROMAXX protein microspheres may be engineered to either release drugs immediately (for pulmonary delivery) or offer sustained release (for injectable delivery).

PROMAXX microsphere technology offers narrow control of the microsphere size and the ability to vary drug release profiles.

CONTRACT SERVICES

We offer a wide spectrum of contract services that provide reliable supply, scientific expertise and bottom line results to meet your development, clinical and commercial outsourcing needs. Our range of contract services includes:

• Biologic API contract manufacturing (clinical and commercial)
• Biopharmaceuticals including monoclonal antibodies and recombinant proteins in various culture media
• Finished product dosage forms (clinical and commercial)

Our finished product dosage form (clinical and commercial) services include:

• Sterile crystallization (cytotoxics)
• Form / fill / finish services, syringe / vial / cartridge filling, lyophilization (including cytotoxics), aseptic powder filling (cytotoxics only), aseptic liquid filling
• Customized inspection / labeling / packaging, automated kitting
• Clinical supply services and blinded labeling / packaging

ENHANCED PHARMACEUTICAL PACKAGING

We offer a proprietary packaging and global franchise to differentiate your drug. We are an industry leader in the technique of using barrier isolator technology for parenterals. We are also the only manufacturer of frozen, asceptically-filled flexible containers for pharma products.

Baxter operates in more than 100 countries worldwide. If you would like more information about Baxter's portfolio of products and services, please contact us using the details below.